The global Animal Vaccines Market is expanding as livestock producers, pet owners, veterinary organizations, and governments increasingly focus on preventing infectious diseases and improving animal health. Animal vaccines help reduce disease transmission, mortality, production losses, and the spread of zoonotic infections. Growing livestock populations, rising companion-animal ownership, increasing demand for animal-derived food products, and stronger awareness of preventive veterinary care are supporting market growth. Advances in recombinant vaccines, DNA vaccines, vector-based vaccines, mRNA technologies, and combination vaccines are also creating new opportunities for manufacturers.
According to Fortune Business Insights, the global animal vaccines market was valued at USD 3.62billion in 2025 and is projected to grow from USD 3.91 billion in 2026 to USD 7.36 billion by 2034, exhibiting a CAGR of 8.22% during the forecast period.
Why is the Animal Vaccines Market Growing?
The rising incidence of infectious and zoonotic diseases in livestock and companion animals is a major factor driving demand for preventive vaccination. Outbreaks can cause significant economic losses for farmers, affect food supply chains, and create public-health concerns.
Animal vaccines are increasingly used for:
The increasing adoption of preventive veterinary healthcare is encouraging farmers and pet owners to vaccinate animals more consistently.
Key Market Trends Shaping Industry Growth
Increasing Demand for Preventive Animal Healthcare
Veterinarians and livestock producers are increasingly emphasizing disease prevention instead of relying only on treatment after infection. Vaccination can help improve herd health and reduce the economic impact of infectious diseases.
Growing Companion Animal Ownership